Years After NCCN Recommended It, FET-PET Finally Has an FDA-Approved Drug
The clinical case was settled before the regulatory one. Clinicians held an NCCN recommendation with no lawful product to act on it.
floretyrosine F 18
The clinical case was settled before the regulatory one. Clinicians held an NCCN recommendation with no lawful product to act on it.